DSGN
Price
$3.83
Change
-$0.04 (-1.03%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
216.29M
79 days until earnings call
VRDN
Price
$13.56
Change
-$0.11 (-0.80%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
1.12B
74 days until earnings call
Interact to see
Advertisement

DSGN vs VRDN

Header iconDSGN vs VRDN Comparison
Open Charts DSGN vs VRDNBanner chart's image
Design Therapeutics
Price$3.83
Change-$0.04 (-1.03%)
Volume$12.09K
Capitalization216.29M
Viridian Therapeutics
Price$13.56
Change-$0.11 (-0.80%)
Volume$13.96K
Capitalization1.12B
DSGN vs VRDN Comparison Chart
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. VRDN commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and VRDN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (DSGN: $3.87 vs. VRDN: $13.67)
Brand notoriety: DSGN and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 108% vs. VRDN: 61%
Market capitalization -- DSGN: $216.29M vs. VRDN: $1.12B
DSGN [@Biotechnology] is valued at $216.29M. VRDN’s [@Biotechnology] market capitalization is $1.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, both DSGN and VRDN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 3 TA indicator(s) are bullish while VRDN’s TA Score has 5 bullish TA indicator(s).

  • DSGN’s TA Score: 3 bullish, 7 bearish.
  • VRDN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VRDN is a better buy in the short-term than DSGN.

Price Growth

DSGN (@Biotechnology) experienced а +15.18% price change this week, while VRDN (@Biotechnology) price change was +8.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

DSGN is expected to report earnings on Aug 11, 2025.

VRDN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.12B) has a higher market cap than DSGN($216M). VRDN YTD gains are higher at: -28.691 vs. DSGN (-37.277). DSGN has higher annual earnings (EBITDA): -67.79M vs. VRDN (-304.76M). VRDN has more cash in the bank: 637M vs. DSGN (230M). DSGN has less debt than VRDN: DSGN (2.14M) vs VRDN (21.2M). VRDN has higher revenues than DSGN: VRDN (302K) vs DSGN (0).
DSGNVRDNDSGN / VRDN
Capitalization216M1.12B19%
EBITDA-67.79M-304.76M22%
Gain YTD-37.277-28.691130%
P/E RatioN/AN/A-
Revenue0302K-
Total Cash230M637M36%
Total Debt2.14M21.2M10%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNVRDN
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSRRX8.54N/A
N/A
Fidelity Strategic Real Return
FTCWX13.49N/A
N/A
Fidelity Advisor Asset Manager 20% C
CBECX10.04N/A
N/A
Allspring Large Cap Value CL C
BIOUX50.19N/A
N/A
Baron Opportunity R6
VKSEX10.06N/A
N/A
Virtus KAR Small-Mid Cap Value C

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with DSGN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then DSGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
+0.07%
DSGN - VRDN
49%
Loosely correlated
+7.50%
DNLI - VRDN
49%
Loosely correlated
-0.22%
OCUL - VRDN
47%
Loosely correlated
-1.16%
CCCC - VRDN
47%
Loosely correlated
N/A
AURA - VRDN
46%
Loosely correlated
N/A
More